APO Research
Talk to an analyst

APO RESEARCH · REPORT

Platinum based Cancer Drug

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

Selected research

Industry Growth & Trends

Global Platinum based Cancer Drug Industry Growth and Trends Forecast to 2032

23 December 2025102 pages

Choose your research edition.

Industry ResearchPlatinum based Cancer Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Platinum based Cancer Drug Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Platinum based Cancer Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Platinum based Cancer Drug Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Platinum based Cancer Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.

The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.

Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.

Read the full market overview

Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.

Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.

Report Scope

This report provides a structured, data-driven view of the global Platinum based Cancer Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Platinum based Cancer Drug market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Platinum based Cancer Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Platinum based Cancer Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Platinum based Cancer Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Platinum based Cancer Drug Market by Company

Sanofi

Hengrui Medicine

ASK Pharma

Yi Bai Pharmaceutical

Qilu Pharmaceutical

Teva

Pfizer

Dr Reddy's Laboratories

Mylan

Sun Pharma

Novartis

Debiopharm

Accord Healthcare

SK Chemicals

Platinum based Cancer Drug Segment by Type

Cisplatin

Oxaliplatin

Carboplatin

Others

Platinum based Cancer Drug Segment by Application

Colorectal Cancer

Ovarian Cancer

Lung Cancer

Others

Platinum based Cancer Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Platinum based Cancer Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Platinum based Cancer Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Platinum based Cancer Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Platinum based Cancer Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Platinum based Cancer Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Cisplatin Table 2. Major Company of Oxaliplatin Table 3. Major Company of Carboplatin Table 4. Major Company of Others Table 5. Global Platinum based Cancer Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 7. Global Platinum based Cancer Drug Sales Market Share in Volume by Type (2021-2026) Table 8. Global Platinum based Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 9. Global Platinum based Cancer Drug Sales Market Share in Value by Type (2021-2026) Table 10. Global Platinum based Cancer Drug Price by Type (2021-2026) & (USD/Unit) Table 11. Global Platinum based Cancer Drug Sales by Type (2027-2032) & (K Units) Table 12. Global Platinum based Cancer Drug Sales Market Share in Volume by Type (2027-2032) Table 13. Global Platinum based Cancer Drug Sales by Type (2027-2032) & (US$ Million) Table 14. Global Platinum based Cancer Drug Sales Market Share in Value by Type (2027-2032) Table 15. Global Platinum based Cancer Drug Price by Type (2027-2032) & (USD/Unit) Table 16. North America Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 17. North America Platinum based Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 19. Europe Platinum based Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 21. Asia-Pacific Platinum based Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 23. Latin America Platinum based Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Platinum based Cancer Drug Sales by Type (2021-2026) & (K Units) Table 25. Middle East and Africa Platinum based Cancer Drug Sales by Type (2021-2026) & (US$ Million) Table 26. Platinum based Cancer Drug Industry Trends Table 27. Platinum based Cancer Drug Industry Drivers Table 28. Platinum based Cancer Drug Industry Opportunities and Challenges Table 29. Platinum based Cancer Drug Industry Restraints Table 30. Global Platinum based Cancer Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Platinum based Cancer Drug Revenue Market Share by Company (2021-2026) Table 32. Global Platinum based Cancer Drug Sales by Company (2021-2026) & (K Units) Table 33. Global Platinum based Cancer Drug Sales Share by Company (2021-2026) Table 34. Global Platinum based Cancer Drug Market Price by Company (2021-2026) & (USD/Unit) Table 35. Global Platinum based Cancer Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Platinum based Cancer Drug Major Company Production Sites and Headquarters Table 37. Global Platinum based Cancer Drug Company, Product Type & Application Table 38. Global Platinum based Cancer Drug Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Platinum based Cancer Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Platinum based Cancer Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Platinum based Cancer Drug Sales by Region (2021-2026) & (K Units) Table 43. Global Platinum based Cancer Drug Sales Market Share in Volume by Region (2021-2026) Table 44. Global Platinum based Cancer Drug Sales by Region (2021-2026) & (US$ Million) Table 45. Global Platinum based Cancer Drug Sales Market Share in Value by Region (2021-2026) Table 46. Global Platinum based Cancer Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 47. Global Platinum based Cancer Drug Sales by Region (2027-2032) & (K Units) Table 48. Global Platinum based Cancer Drug Sales Market Share in Volume by Region (2027-2032) Table 49. Global Platinum based Cancer Drug Sales by Region (2027-2032) & (US$ Million) Table 50. Global Platinum based Cancer Drug Sales Market Share in Value by Region (2027-2032) Table 51. Global Platinum based Cancer Drug Sales (K Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2027-2032) Table 52. Global Platinum based Cancer Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 54. Global Platinum based Cancer Drug Sales Market Share in Volume by Application (2021-2026) Table 55. Global Platinum based Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 56. Global Platinum based Cancer Drug Sales Market Share in Value by Application (2021-2026) Table 57. Global Platinum based Cancer Drug Price by Application (2021-2026) & (USD/Unit) Table 58. Global Platinum based Cancer Drug Sales by Application (2027-2032) & (K Units) Table 59. Global Platinum based Cancer Drug Sales Market Share in Volume by Application (2027-2032) Table 60. Global Platinum based Cancer Drug Sales by Application (2027-2032) & (US$ Million) Table 61. Global Platinum based Cancer Drug Sales Market Share in Value by Application (2027-2032) Table 62. Global Platinum based Cancer Drug Price by Application (2027-2032) & (USD/Unit) Table 63. North America Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 64. North America Platinum based Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 66. Europe Platinum based Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 68. Asia-Pacific Platinum based Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 70. Latin America Platinum based Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Platinum based Cancer Drug Sales by Application (2021-2026) & (K Units) Table 72. Middle East and Africa Platinum based Cancer Drug Sales by Application (2021-2026) & (US$ Million) Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 76. Sanofi Platinum based Cancer Drug Product Portfolio Table 77. Sanofi Recent Development Table 78. Hengrui Medicine Company Information Table 79. Hengrui Medicine Business Overview Table 80. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 81. Hengrui Medicine Platinum based Cancer Drug Product Portfolio Table 82. Hengrui Medicine Recent Development Table 83. ASK Pharma Company Information Table 84. ASK Pharma Business Overview Table 85. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 86. ASK Pharma Platinum based Cancer Drug Product Portfolio Table 87. ASK Pharma Recent Development Table 88. Yi Bai Pharmaceutical Company Information Table 89. Yi Bai Pharmaceutical Business Overview Table 90. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 91. Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio Table 92. Yi Bai Pharmaceutical Recent Development Table 93. Qilu Pharmaceutical Company Information Table 94. Qilu Pharmaceutical Business Overview Table 95. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 96. Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio Table 97. Qilu Pharmaceutical Recent Development Table 98. Teva Company Information Table 99. Teva Business Overview Table 100. Teva Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 101. Teva Platinum based Cancer Drug Product Portfolio Table 102. Teva Recent Development Table 103. Pfizer Company Information Table 104. Pfizer Business Overview Table 105. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 106. Pfizer Platinum based Cancer Drug Product Portfolio Table 107. Pfizer Recent Development Table 108. Dr Reddy's Laboratories Company Information Table 109. Dr Reddy's Laboratories Business Overview Table 110. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 111. Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio Table 112. Dr Reddy's Laboratories Recent Development Table 113. Mylan Company Information Table 114. Mylan Business Overview Table 115. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 116. Mylan Platinum based Cancer Drug Product Portfolio Table 117. Mylan Recent Development Table 118. Sun Pharma Company Information Table 119. Sun Pharma Business Overview Table 120. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 121. Sun Pharma Platinum based Cancer Drug Product Portfolio Table 122. Sun Pharma Recent Development Table 123. Novartis Company Information Table 124. Novartis Business Overview Table 125. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 126. Novartis Platinum based Cancer Drug Product Portfolio Table 127. Novartis Recent Development Table 128. Debiopharm Company Information Table 129. Debiopharm Business Overview Table 130. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 131. Debiopharm Platinum based Cancer Drug Product Portfolio Table 132. Debiopharm Recent Development Table 133. Accord Healthcare Company Information Table 134. Accord Healthcare Business Overview Table 135. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 136. Accord Healthcare Platinum based Cancer Drug Product Portfolio Table 137. Accord Healthcare Recent Development Table 138. SK Chemicals Company Information Table 139. SK Chemicals Business Overview Table 140. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 141. SK Chemicals Platinum based Cancer Drug Product Portfolio Table 142. SK Chemicals Recent Development Table 143. North America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 144. North America Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 145. North America Platinum based Cancer Drug Sales Market Share by Country (2021-2026) Table 146. North America Platinum based Cancer Drug Sales Forecast by Country (2027-2032) & (K Units) Table 147. North America Platinum based Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 148. North America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Platinum based Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Platinum based Cancer Drug Market Share by Country (2021-2026) Table 151. North America Platinum based Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Platinum based Cancer Drug Market Share Forecast by Country (2027-2032) Table 153. Europe Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 154. Europe Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 155. Europe Platinum based Cancer Drug Sales Market Share by Country (2021-2026) Table 156. Europe Platinum based Cancer Drug Sales Forecast by Country (2027-2032) & (K Units) Table 157. Europe Platinum based Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 158. Europe Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Europe Platinum based Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 160. Europe Platinum based Cancer Drug Market Share by Country (2021-2026) Table 161. Europe Platinum based Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Europe Platinum based Cancer Drug Market Share Forecast by Country (2027-2032) Table 163. Asia-Pacific Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 164. Asia-Pacific Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 165. Asia-Pacific Platinum based Cancer Drug Sales Market Share by Country (2021-2026) Table 166. Asia-Pacific Platinum based Cancer Drug Sales Forecast by Country (2027-2032) & (K Units) Table 167. Asia-Pacific Platinum based Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 168. Asia-Pacific Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Asia-Pacific Platinum based Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 170. Asia-Pacific Platinum based Cancer Drug Market Share by Country (2021-2026) Table 171. Asia-Pacific Platinum based Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Asia-Pacific Platinum based Cancer Drug Market Share Forecast by Country (2027-2032) Table 173. Latin America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 174. Latin America Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 175. Latin America Platinum based Cancer Drug Sales Market Share by Country (2021-2026) Table 176. Latin America Platinum based Cancer Drug Sales Forecast by Country (2027-2032) & (K Units) Table 177. Latin America Platinum based Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 178. Latin America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 179. Latin America Platinum based Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 180. Latin America Platinum based Cancer Drug Market Share by Country (2021-2026) Table 181. Latin America Platinum based Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 182. Latin America Platinum based Cancer Drug Market Share Forecast by Country (2027-2032) Table 183. Middle East and Africa Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 184. Middle East and Africa Platinum based Cancer Drug Sales by Country (2021-2026) & (K Units) Table 185. Middle East and Africa Platinum based Cancer Drug Sales Market Share by Country (2021-2026) Table 186. Middle East and Africa Platinum based Cancer Drug Sales Forecast by Country (2027-2032) & (K Units) Table 187. Middle East and Africa Platinum based Cancer Drug Sales Market Share Forecast by Country (2027-2032) Table 188. Middle East and Africa Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 189. Middle East and Africa Platinum based Cancer Drug Market Size by Country (2021-2026) & (US$ Million) Table 190. Middle East and Africa Platinum based Cancer Drug Market Share by Country (2021-2026) Table 191. Middle East and Africa Platinum based Cancer Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 192. Middle East and Africa Platinum based Cancer Drug Market Share Forecast by Country (2027-2032) Table 193. Key Raw Materials Table 194. Raw Materials Key Suppliers Table 195. Platinum based Cancer Drug Distributors List Table 196. Platinum based Cancer Drug Customers List Table 197. Research Programs/Design for This Report Table 198. Authors List of This Report Table 199. Secondary Sources Table 200. Primary Sources List of Figures Figure 1. Platinum based Cancer Drug Image Figure 2. Global Platinum based Cancer Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Platinum based Cancer Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Platinum based Cancer Drug Sales (2021-2032) & (K Units) Figure 5. Cisplatin Image Figure 6. Global Cisplatin Sales YoY Growth (2021-2032) & (K Units) Figure 7. Oxaliplatin Image Figure 8. Global Oxaliplatin Sales YoY Growth (2021-2032) & (K Units) Figure 9. Carboplatin Image Figure 10. Global Carboplatin Sales YoY Growth (2021-2032) & (K Units) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 13. Global Platinum based Cancer Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Platinum based Cancer Drug Market Share by Type 2025 VS 2032 Figure 15. North America Platinum based Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 16. North America Platinum based Cancer Drug Sales Market Share in Value by Type in 2025 Figure 17. Europe Platinum based Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 18. Europe Platinum based Cancer Drug Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Value by Type in 2025 Figure 21. Latin America Platinum based Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Platinum based Cancer Drug Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Platinum based Cancer Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Colorectal Cancer Image Figure 28. Global Colorectal Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 29. Ovarian Cancer Image Figure 30. Global Ovarian Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 31. Lung Cancer Image Figure 32. Global Lung Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Platinum based Cancer Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Platinum based Cancer Drug Market Share by Application 2025 VS 2032 Figure 37. North America Platinum based Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Platinum based Cancer Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Platinum based Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Platinum based Cancer Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Platinum based Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Platinum based Cancer Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Platinum based Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Platinum based Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Platinum based Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Platinum based Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Platinum based Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Platinum based Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Platinum based Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Platinum based Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Platinum based Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Platinum based Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Platinum based Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Platinum based Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Platinum based Cancer Drug Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Platinum based Cancer Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Platinum based Cancer Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Platinum based Cancer Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Platinum based Cancer Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Platinum based Cancer Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Cisplatin
  • Oxaliplatin
  • Carboplatin
  • Others
Applications
  • Colorectal Cancer
  • Ovarian Cancer
  • Lung Cancer
  • Others
Companies covered
  • Sanofi
  • Hengrui Medicine
  • ASK Pharma
  • Yi Bai Pharmaceutical
  • Qilu Pharmaceutical
  • Teva
  • Pfizer
  • Dr Reddy's Laboratories
  • Mylan
  • Sun Pharma
  • Novartis
  • Debiopharm
  • Accord Healthcare
  • SK Chemicals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Platinum based Cancer Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Platinum based Cancer Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Platinum based Cancer Drug Market by Type
  6. 1.3.1 Cisplatin
  7. 1.3.2 Oxaliplatin
  8. 1.3.3 Carboplatin
  9. 1.3.4 Others
  10. 1.4 Global Platinum based Cancer Drug Market Size by Type
  11. 1.4.1 Global Platinum based Cancer Drug Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Platinum based Cancer Drug Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Platinum based Cancer Drug Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Platinum based Cancer Drug Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Platinum based Cancer Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Platinum based Cancer Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Platinum based Cancer Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Platinum based Cancer Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Platinum based Cancer Drug Industry Trends
  2. 2.2 Platinum based Cancer Drug Industry Drivers
  3. 2.3 Platinum based Cancer Drug Industry Opportunities and Challenges
  4. 2.4 Platinum based Cancer Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Platinum based Cancer Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Platinum based Cancer Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Platinum based Cancer Drug Price (2021-2026)
  4. 3.4 Global Platinum based Cancer Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Platinum based Cancer Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Platinum based Cancer Drug Company, Product Type & Application
  7. 3.7 Global Platinum based Cancer Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Platinum based Cancer Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Platinum based Cancer Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Platinum based Cancer Drug Tier 1, Tier 2, and Tier 3
4 Platinum based Cancer Drug Regional Status and Outlook
  1. 4.1 Global Platinum based Cancer Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Platinum based Cancer Drug Historic Market Size by Region
  3. 4.2.1 Global Platinum based Cancer Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Platinum based Cancer Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Platinum based Cancer Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Platinum based Cancer Drug Forecasted Market Size by Region
  7. 4.3.1 Global Platinum based Cancer Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Platinum based Cancer Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Platinum based Cancer Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Platinum based Cancer Drug by Application
  1. 5.1 Platinum based Cancer Drug Market by Application
  2. 5.1.1 Colorectal Cancer
  3. 5.1.2 Ovarian Cancer
  4. 5.1.3 Lung Cancer
  5. 5.1.4 Others
  6. 5.2 Global Platinum based Cancer Drug Market Size by Application
  7. 5.2.1 Global Platinum based Cancer Drug Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Platinum based Cancer Drug Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Platinum based Cancer Drug Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Platinum based Cancer Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Platinum based Cancer Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Platinum based Cancer Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Platinum based Cancer Drug Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Platinum based Cancer Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Platinum based Cancer Drug Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Hengrui Medicine
  8. 6.2.1 Hengrui Medicine Company Information
  9. 6.2.2 Hengrui Medicine Business Overview
  10. 6.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hengrui Medicine Platinum based Cancer Drug Product Portfolio
  12. 6.2.5 Hengrui Medicine Recent Developments
  13. 6.3 ASK Pharma
  14. 6.3.1 ASK Pharma Company Information
  15. 6.3.2 ASK Pharma Business Overview
  16. 6.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 ASK Pharma Platinum based Cancer Drug Product Portfolio
  18. 6.3.5 ASK Pharma Recent Developments
  19. 6.4 Yi Bai Pharmaceutical
  20. 6.4.1 Yi Bai Pharmaceutical Company Information
  21. 6.4.2 Yi Bai Pharmaceutical Business Overview
  22. 6.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Product Portfolio
  24. 6.4.5 Yi Bai Pharmaceutical Recent Developments
  25. 6.5 Qilu Pharmaceutical
  26. 6.5.1 Qilu Pharmaceutical Company Information
  27. 6.5.2 Qilu Pharmaceutical Business Overview
  28. 6.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Product Portfolio
  30. 6.5.5 Qilu Pharmaceutical Recent Developments
  31. 6.6 Teva
  32. 6.6.1 Teva Company Information
  33. 6.6.2 Teva Business Overview
  34. 6.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Teva Platinum based Cancer Drug Product Portfolio
  36. 6.6.5 Teva Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Platinum based Cancer Drug Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Dr Reddy's Laboratories
  44. 6.8.1 Dr Reddy's Laboratories Company Information
  45. 6.8.2 Dr Reddy's Laboratories Business Overview
  46. 6.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Product Portfolio
  48. 6.8.5 Dr Reddy's Laboratories Recent Developments
  49. 6.9 Mylan
  50. 6.9.1 Mylan Company Information
  51. 6.9.2 Mylan Business Overview
  52. 6.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Mylan Platinum based Cancer Drug Product Portfolio
  54. 6.9.5 Mylan Recent Developments
  55. 6.10 Sun Pharma
  56. 6.10.1 Sun Pharma Company Information
  57. 6.10.2 Sun Pharma Business Overview
  58. 6.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Sun Pharma Platinum based Cancer Drug Product Portfolio
  60. 6.10.5 Sun Pharma Recent Developments
  61. 6.11 Novartis
  62. 6.11.1 Novartis Company Information
  63. 6.11.2 Novartis Business Overview
  64. 6.11.3 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Novartis Platinum based Cancer Drug Product Portfolio
  66. 6.11.5 Novartis Recent Developments
  67. 6.12 Debiopharm
  68. 6.12.1 Debiopharm Company Information
  69. 6.12.2 Debiopharm Business Overview
  70. 6.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Debiopharm Platinum based Cancer Drug Product Portfolio
  72. 6.12.5 Debiopharm Recent Developments
  73. 6.13 Accord Healthcare
  74. 6.13.1 Accord Healthcare Company Information
  75. 6.13.2 Accord Healthcare Business Overview
  76. 6.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Accord Healthcare Platinum based Cancer Drug Product Portfolio
  78. 6.13.5 Accord Healthcare Recent Developments
  79. 6.14 SK Chemicals
  80. 6.14.1 SK Chemicals Company Information
  81. 6.14.2 SK Chemicals Business Overview
  82. 6.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 SK Chemicals Platinum based Cancer Drug Product Portfolio
  84. 6.14.5 SK Chemicals Recent Developments
7 North America by Country
  1. 7.1 North America Platinum based Cancer Drug Sales by Country
  2. 7.1.1 North America Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Platinum based Cancer Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Platinum based Cancer Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Platinum based Cancer Drug Market Size by Country
  6. 7.2.1 North America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Platinum based Cancer Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Platinum based Cancer Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Platinum based Cancer Drug Sales by Country
  2. 8.1.1 Europe Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Platinum based Cancer Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Platinum based Cancer Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Platinum based Cancer Drug Market Size by Country
  6. 8.2.1 Europe Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Platinum based Cancer Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Platinum based Cancer Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Platinum based Cancer Drug Sales by Country
  2. 9.1.1 Asia-Pacific Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Platinum based Cancer Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Platinum based Cancer Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Platinum based Cancer Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Platinum based Cancer Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Platinum based Cancer Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Platinum based Cancer Drug Sales by Country
  2. 10.1.1 South America Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Platinum based Cancer Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Platinum based Cancer Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Platinum based Cancer Drug Market Size by Country
  6. 10.2.1 South America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Platinum based Cancer Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Platinum based Cancer Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Platinum based Cancer Drug Sales by Country
  2. 11.1.1 Middle East and Africa Platinum based Cancer Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Platinum based Cancer Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Platinum based Cancer Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Platinum based Cancer Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Platinum based Cancer Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Platinum based Cancer Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Platinum based Cancer Drug Value Chain Analysis
  2. 12.1.1 Platinum based Cancer Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Platinum based Cancer Drug Production Mode & Process
  7. 12.2 Platinum based Cancer Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Platinum based Cancer Drug Distributors
  10. 12.2.3 Platinum based Cancer Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst